However, how insulin and hyperandrogenism contribute to the adverse lipid profile present in PCOS, which includes altered concentrations of phospholipids, FFAs, and bioactive lipid metabolites derived from polyunsaturated fatty acids (PUFAs), remains poorly defined. This evidence concerns the gene INS and polycystic ovary syndrome.